Modafinil and Memory: Effects of Modafinil on Morris Water Maze Learning and Pavlovian Fear Conditioning

Behavioral Neuroscience

Volumn 123, Issue 2, 2009, Pages 257-266

  Shuman, Tristan ^a   Wood, Suzanne C ^a   Anagnostaras, Stephan G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fear conditioning; hippocampus; memory; modafinil; Morris water maze

Indexed keywords

AMPHETAMINE; COCAINE; MODAFINIL;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEAR; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MENTAL HEALTH; MOUSE; NONHUMAN; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; FREEZING REACTION, CATALEPTIC; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; REACTION TIME; TIME FACTORS;

EID: 65249154085     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014366     Document Type: Article

References (51)

1. Anagnostaras S.G., Gale G.D., and Fanselow M.S. The hippocampus and contextual fear conditioning: Recent controversies and advances. Hippocampus 11 (2001) 8-17
2. Anagnostaras S.G., Josselyn S.A., Frankland P.W., and Silva A.J. Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. Learning and Memory 7 (2000) 58-72
3. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nature Neuroscience 6 (2003) 51-58
4. Bastuji H., and Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Progress in Neuro-Psychopharmacology and Biological Psychiatry 12 (1988) 695-700
5. Beracochea D., Cagnard B., Celerier A., le Merrer J., Pere M., and Pierard C. First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice. Learning & Memory 12 (2001) 375-378
6. Beracochea D., Celerier A., Borde N., Valleau M., Peres M., and Pierard C. Improvement of learning processes following chronic systemic administration of modafinil in mice. Pharmacology, Biochemistry and Behavior 73 (2002) 723-728
7. Beracochea D., Celerier A., Peres M., and Pierard C. Enhancement of learning processes following an acute modafinil injection in mice. Pharmacology, Biochemistry and Behavior 76 (2003) 473-479
8. Brower V. Loosening addiction's deadly grip. Recent research paints a picture of addiction as a progressive, chronic neurological disease that wreaks havoc with brain chemistry. European Molecular Biology Organization 7 (2006) 140-142
9. Cephalon. FDA Approved Labeling Text for NDA 20-717/S-005 & S-008. Provigil® (modafinil) Tablets (C-IV), Approved-23-Jan-2004. Available online at http://www.biopsychiatry.com/modafinil-provigil.pdf
10. Clarke R.E., Broadbent N.J., and Squire L.R. Hippocampus and remote spatial memory in rats. Hippocampus 15 (2005) 260-272
11. Deroche-Gamonet V., Darnaudery M., Bruins-Slot L., Piat F., Le Moal M., and Piazza P.V. Study of the addictive potential of modafinil in naïve and cocaine-experienced rats. Psychopharmacology 161 (2002) 387-395
12. Engber T.M., Dennis S.A., Jones B.E., Miller M.S., and Contreras P.C. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: Comparison with amphetamine. Neuroscience 87 (1998) 905-911
13. Fanselow M.S. Conditioned and unconditional components of post-shock freezing. Pavlovian Journal of Biological Sciences 15 (1980) 177-182
14. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F., and Fuxe K. Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biological Psychiatry 42 (1997) 1181-1183
15. Ferraro L., Antonelli T., O'Connor W.T., Tangenelli S., Rambert F., and Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: Evidence for a preferential inhibition of striato-pallidal GABA transmission. Neuroscience Letters 253 (1998) 135-138
16. Ferraro L., Antonelli T., Tangenelli S., O'Connor W.T., Perez de la Mora M., Mendez-Franco J., et al. The vigilance-promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: Prevention by local GABA-A receptor blockade. Neuropsychopharmacology 20 (1999) 346-356
17. Ferraro L., Fuxe K., Tanganelli S., Fernandez M., Rambert F.A., and Antonelli T. Amplification of cortical serotonin release: A further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology 39 (2000) 1974-1983
18. Gale G.D., Anagnostaras S.G., Godsil B.P., Mitchell S., Nozawa T., Sage J.R., et al. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. Journal of Neuroscience 24 (2004) 3810-3815
19. Gallopin T., Luppi P.H., Rambert F.A., Frydman A., and Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: An in vitro pharmacologic study. Sleep 27 (2004) 19-25
20. Garreau J. A Dose of Genius: 'Smart Pills' Are on The Rise. But Is Taking Them Wise?. Washington Post (2006, June 11)
21. Giurgea C. The nootropic concept and it's prospective implications. Drug Development Research 2 (1982) 441-446
22. Kaufman K.R., Menza M.A., and Fitzsimmons A. Modafinil monotherapy for depression. European Psychiatry 17 (2002) 167-169
23. Lin J.S., Hou Y., and Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proceedings of the National Academy of Sciences, USA 93 (1996) 14128-14133
24. Ling W., Rawson R., Shoptaw S., and Ling W. Management of methamphetamine abuse and dependence. Current Psychiatry Reports 8 (2006) 345-354
25. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. Journal of Pharmacology and Experimental Therapeutics 319 (2006) 561-569
26. Markham C.M., Yang M., and Blanchard D.C. Effects of D-amphetamine on defensive behaviors related to fear and anxiety. Pharmacology, Biochemistry, and Behavior 4 (2006) 490-499
27. Morgan R.E., Crowley J.M., Smith R.H., LaRoche R.B., and Dopheide M.M. Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats. Pharmacology, Biochemistry, and Behavior 86 (2007) 531-541
28. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 11 (1984) 47-60
29. Müller U., Steffenhagen N., Regenthal R., and Bublak P. Effects of modafinil on working memory processes in humans. Psychopharmacology 177 (2004) 161-169
30. Nieves A.V., and Lang A.E. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clinical Neuropharmacology 25 (2002) 111-114
31. O'Connor A. Wakefulness finds a powerful ally. New York Times (2004, June 29)
32. Pack A.I., Black J.E., Schwartz J.R., and Matheson J.K. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 164 (2001) 1675-1681
33. Pierard C., Liscia P., Valleau M., Drouet I., Chauveau F., Huart B., et al. Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice. Pharmacology, Biochemistry, and Behavior 83 (2006) 1-8
34. Pigeau R., Naitoh P., Buguet A., McCann C., Baranski J., Taylor M., et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work: I. Effects on mood, fatigue, cognitive performance and body temperature. Journal of Sleep Research 4 (1995) 212-228
35. Randall D.C., Shneerson J.M., and File S.E. Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacology, Biochemistry and Behavior 82 (2005) 133-139
36. Randall D.C., Shneerson J.M., Plaha K.K., and File S.E. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Human Psychopharmacology 18 (2003) 163-173
37. Roth T., and Roehrs T.A. Etiologies and sequelae of excessive daytime sleepiness. Clinical Therapeutics 18 (1996) 562-576
38. Saper C.B., and Scammell T.E. Modafinil: A drug in search of a mechanism. Sleep 27 (2004) 11-12
39. Sherin J.E., Shiromani P.J., McCarley R.W., and Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science 271 (1996) 216-219
40. Sofuoglu M., Waters A.J., and Mooney M. Modafinil and nicotine interactions in abstinent smokers. Human Psychopharmacology 23 (2008) 21-30
41. Steele R.J., and Morris R.G.M. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus 9 (1999) 118-136
42. Taylor F.B., and Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Journal of Child and Adolescent Psychopharmacology 10 (2000) 311-320
43. Turner D.C., Clark L., Pomarol-Clotet E., McKenna P., Robbins T.W., and Sahakian B.J. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29 (2004) 1363-1373
44. Turner D.C., Robbins T.W., Clark L., Aron A.R., Dowson J., and Sahakian B.J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165 (2003) 260-269
45. Ward C.P., Harsh J.R., York K.M., Stewart K.L., and McCoy J.G. Modafinil facilitates performance on a delayed nonmatching to position swim task in rats. Pharmacology, Biochemistry and Behavior 78 (2004) 735-741
46. Waters K.A., Burnham K.E., O'Connor D., Dawson G.R., and Dias R. Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. Journal of Psychopharmacology 19 (2005) 149-158
47. Wiltgen B.J., Sanders M.J., Anagnostaras S.G., Sage J.R., and Fanselow M.S. Context fear learning in the absence of the hippocampus. Journal of Neuroscience 26 (2006) 5484-5491
48. Wisor J.P., and Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
49. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. The Journal of Neuroscience 21 (2001) 1787-1794
50. Wood, S. C., & Anagnostaras, S. G. (in press). Memory and psychostimulants: Modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice. Psychopharmacology
51. Wood S.C., Fay J., Sage J.R., and Anagnostaras S.G. Cocaine and Pavlovian fear conditioning: Dose-effect analysis. Behavioral Brain Research 176 (2007) 244-250